Diagnosis and monitoring of breast cancer with a novel circulating tumor cells enrichment device
CTCs and this platform both have practical implications in clinical breast cancer diagnosis and monitoring.
Authors
- Xiaorong Yang (ORCID: https://orcid.org/0000-0002-1775-4832)
- Lin Guo (ORCID: https://orcid.org/0000-0002-1277-3954)
- Weizhong Shi (ORCID: https://orcid.org/0000-0001-5426-9572)
- Zhiyun Gong (ORCID: https://orcid.org/0000-0002-2071-3150)
- Yan Chen (ORCID: https://orcid.org/0000-0002-6091-2525)
- Yi Zhang (ORCID: https://orcid.org/0000-0002-5388-9574)
- Tiantian Dai
- Feng Dong (ORCID: https://orcid.org/0000-0001-7979-5464)
- Aoshuang Li
- Renquan Lu
- Jing Yan (ORCID: https://orcid.org/0000-0003-2824-1431)
Institutions
- Shanghai Medical College of Fudan University (CN)
- Fudan University (CN)
- Soochow University (CN)
- Shanghai International Medical Center (CN)
- Fudan University Shanghai Cancer Center (CN)
- Eden Medical (US)
- First Affiliated Hospital of Soochow University (CN)
Publication Details
- Journal
- Biomarkers in Medicine
- Published
- 2025-06-22
- DOI
- https://doi.org/10.1080/17520363.2025.2521255
- Primary Topic
- Cancer Cells and Metastasis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China